Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities

The combined power of Syntellis and Stratasan technologies will accelerate data-driven, comprehensive decision-making for healthcare organizations across the country.

CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced a definitive agreement to acquire Stratasan, an industry leader in advanced healthcare market intelligence and data analytics.

Through this acquisition, Syntellis will expand its suite of intelligent planning and performance solutions by adding Stratasan’s powerful strategic growth capabilities. This combination will deliver unparalleled intelligence and insights to healthcare leaders and create the industry’s most robust set of tools designed to help providers and other healthcare organizations strategically determine where, when and how to grow.

“Now more than ever, healthcare organizations need data and intelligence solutions that help them grow profitably and improve outcomes in the face of extraordinary changes and challenges,” said Flint Brenton, CEO of Syntellis. “With the powerful combination of Syntellis’ leading software, data and intelligence solutions and Stratasan’s advanced analytics and market intelligence, we’ll connect operational, financial and strategic data to empower healthcare leaders to improve their performance, deliver exceptional outcomes and maximize their impact in the communities they serve.”

Stratasan is a nationally recognized provider of data analytics software and services for hospitals, ancillary care centers, healthcare consultants, and payers, helping them improve the efficiency and effectiveness of strategic growth efforts by delivering advanced market intelligence and data analytics.

“For more than a decade, leading national healthcare organizations have relied on our software and services to provide a clear picture of what’s going on in their target markets — so they know where to grow,” said Jason Moore, CEO of Stratasan. “We look forward to furthering our mission as part of Syntellis and continuing to help hospitals and healthcare entities across the country better serve their markets and maximize strategic impact.”

Thoma Bravo and Madison Dearborn Partners are Syntellis’ primary investors.

Ernst & Young Global Limited acted as financial advisor and Kirkland & Ellis LLP served as legal advisor to Syntellis. Canaccord Genuity, LLC acted as financial advisor and McDermott Will & Emery LLP served as legal advisor to Stratasan.

About Syntellis Performance Solutions

Syntellis Performance Solutions provides innovative enterprise performance management software, data and intelligence solutions for healthcare, higher education and financial institutions. Syntellis’ solutions include Axiom and Connected Analytics software, which help finance professionals elevate performance by acquiring insights, accelerating decisions and advancing their business plans. With over 2,800 organizations and 450,000 users relying on its solutions, Syntellis has proven industry expertise in helping organizations transform their visions into reality. For more information, please visit

LinkedIn: Syntellis Performance Solutions
Twitter: @Syntellis